Testosterone and blood pressure regulation

Kidney and Blood Pressure Research

Volumn 31, Issue 2, 2008, Pages 71-79

  Kienitz, Tina ^a   Quinkler, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Androgens; Blood pressure; Hypertension; Sex difference; Testosterone

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANGIOTENSIN II; CYCLOHEXIMIDE; DACTINOMYCIN; ENALAPRIL; ENDOTHELIN 1; ESTRADIOL; ESTROGEN DERIVATIVE; FINASTERIDE; FLUTAMIDE; NORADRENALIN; PRASTERONE; PROGESTERONE DERIVATIVE; TESTOSTERONE; THROMBOXANE A2;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CLINICAL TRIAL; DRUG EFFECT; DRUG INHIBITION; HEART VENTRICLE HYPERTROPHY; HORMONE ACTION; HUMAN; HYPERTENSION; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; NATRIURESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEX DIFFERENCE; ST SEGMENT DEPRESSION; UPREGULATION; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ATHEROSCLEROSIS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERTENSION; MALE; RENIN-ANGIOTENSIN SYSTEM; SEX FACTORS; TESTOSTERONE; VASOCONSTRICTION;

EID: 43049096819     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000119417     Document Type: Review

References (103)

1. Harshfield GA, Alpert BS, Pulliam DA, et al: Ambulatory blood pressure recordings in children and adolescents. Pediatrics 1994;94:180-184.
2. Himmelmann A, Svensson A, Hansson L: Influence of sex on blood pressure and left ventricular mass in adolescents: the Hypertension in Pregnancy Offspring Study. J Hum Hypertens 1994;8:485-490.
3. Wiinberg N, Hoegholm A, Christensen HR, et al: 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 1995;8:978-986.
4. Yong LC, Kuller LH, Rutan G, et al: Longitudinal study of blood pressure: changes and determinants from adolescence to middle age. The Dormont High School follow-up study, 1957-1963 to 1989-1990. Am J Epidemiol 1993;138:973-983.
5. Stamler J, Stamler R, Riedlinger WF, et al: Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) program, 1973 through 1975. JAMA 1976;235:2299-2306.
6. Burt VL, Whelton P, Roccella EJ, et al: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313.
7. Reckelhoff JF: Gender differences in the regulation of blood pressure. Hypertension 2001;37:1199-1208.
8. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1995;273:199-208.
9. Akkad AA, Halligan AW, Abrams K, et al: Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet Gynecol 1997;89:97-103.
10. Pripp U, Hall G, Csemiczky G, et al: A randomized trial on effects of hormone therapy on ambulatory blood pressure and lipoprotein levels in women with coronary artery disease. J Hypertens 1999;17:1379-1386.
11. Anastos K, Charney P, Charon RA, et al: Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine. Ann Intern Med 1991;115:287-293.
12. Khaw KT, Barrett-Connor E: Blood pressure and endogenous testosterone in men: an inverse relationship. J Hypertens 1988;6:329-332.
13. Messerli FH, Garavaglia GE, Schmieder RE, et al: Disparate cardiovascular findings in men and women with essential hypertension. Ann Intern Med 1987;107:158-161.
14. Phillips GB, Pinkernell BH, Jing TY: The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb 1994;14:701-706.
15. Kalin MF, Zumoff B: Sex hormones and coronary disease: a review of the clinical studies. Steroids 1990;55:330-352.
16. Chen MJ, Yang WS, Yang JH, et al: Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension 2007;49:1442-1447.
17. Mattsson LA, Cullberg G, Hamberger L, et al: Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease. Fertil Steril 1984;42:579-584.
18. Soranno D, Prasad V, David R, et al: Hypertension and virilization caused by a unique desoxycorticosterone- and androgen-secreting adrenal adenoma. J Pediatr Endocrinol Metab 1999;12:215-220.
19. Talbott E, Guzick D, Clerici A, et al: Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 1995;15:821-826.
20. Sullivan ML, Martinez CM, Gennis P, et al: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 1998;41:1-15.
21. Hughes GS, Mathur RS, Margolius HS: Sex steroid hormones are altered in essential hypertension. J Hypertens 1989;7:181-187.
22. Phillips GB, Jing TY, Resnick LM, et al: Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension. J Hypertens 1993;11:699-702.
23. English KM, Mandour O, Steeds RP, et al: Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J 2000;21:890-894.
24. English KM, Steeds R, Jones TH, et al: Testosterone and coronary heart disease: is there a link? QJM 1997;90:787-791.
25. Chen YF, Meng QC: Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci 1991;48:85-96.
26. Reckelhoff JF, Zhang H, Granger JP: Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 1998;31:435-439.
27. Reckelhoff JF, Zhang H, Srivastava K: Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension 2000;35:480-483.
28. Crofton JT, Share L: Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats. Hypertension 1997;29:494-499.
29. Rowland NE, Fregly MJ: Role of gonadal hormones in hypertension in the Dahl salt-sensitive rat. Clin Exp Hypertens A 1992;14:367-375.
30. Ouchi Y, Share L, Crofton JT, et al: Sex difference in the development of deoxycorticosterone-salt hypertension in the rat. Hypertension 1987;9:172-177.
31. Ashton N, Balment RJ: Sexual dimorphism in renal function and hormonal status of New Zealand genetically hypertensive rats. Acta Endocrinol (Copenh) 1991;124:91-97.
32. Ganten U, Schroder G, Witt M, et al: Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment. J Hypertens 1989;7:721-726.
33. Iams SG, Wexler BC: Retardation in the development of spontaneous hypertension in SH rats by gonadectomy. J Lab Clin Med 1977;90:997-1003.
34. Oparil S, Levine RL, Chen SJ, et al: Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment. Circulation 1997;95:1301-1307.
35. Hanke H, Lenz C, Hess B, et al: Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall. Circulation 2001;103:1382-1385.
36. Yue P, Chatterjee K, Beale C, et al: Testosterone relaxes rabbit coronary arteries and aorta. Circulation 1995;91:1154-1160.
37. Webb CM, McNeill JG, Hayward CS, et al: Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation 1999;100:1690-1696.
38. Teoh H, Quan A, Leung SW, et al: Differential effects of 17beta-estradiol and testosterone on the contractile responses of porcine coronary arteries. Br J Pharmacol 2000;129:1301-1308.
39. Tep-areenan P, Kendall DA, Randall MD: Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. Br J Pharmacol 2002;135:735-740.
40. Deenadayalu VP, White RE, Stallone JN, et al: Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am J Physiol Heart Circ Physiol 2001;281:H1720-H1727.
41. 2+ entry mechanisms of arterial vasoconstriction by sex hormones. Clin Exp Pharmacol Physiol 1999;26:707-715.
42. i during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone. J Pharmacol Exp Ther 1999;291:44-52.
43. 2+ entry mechanisms of coronary vasoconstriction. Arterioscler Thromb Vasc Biol 1999;19:1034-1040.
44. Jones RD, Hugh Jones T, Channer KS: The influence of testosterone upon vascular reactivity. Eur J Endocrinol 2004;151:29-37.
45. Jones RD, Pugh PJ, Jones TH, et al: The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action? Br J Pharmacol 2003;138:733-744.
46. Goetz RM, Thatte HS, Prabhakar P, et al: Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1999;96:2788-2793.
47. Honda H, Unemoto T, Kogo H: Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats. Hypertension 1999;34:1232-1236.
48. Jones RD, English KM, Pugh PJ, et al: Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action. J Cardiovasc Pharmacol 2002;39:814-823.
49. Jaffe MD: Effect of testosterone cypionate on postexercise ST segment depression. Br Heart J 1977;39:1217-1222.
50. Rosano GM, Leonardo F, Pagnotta P, et al: Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 1999;99:1666-1670.
51. Webb CM, Adamson DL, de Zeigler D, et al: Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol 1999;83:437-439, A9.
52. Kumai T, Tanaka M, Watanabe M, et al: Elevated tyrosine hydroxylase mRNA levels in the adrenal medulla of spontaneously hypertensive rats. Jpn J Pharmacol 1994;65:367-369.
53. Kumai T, Tanaka M, Watanabe M, et al: Influence of androgen on tyrosine hydroxylase mRNA in adrenal medulla of spontaneously hypertensive rats. Hypertension 1995;26:208-212.
54. Zukowska-Grojec Z: Neuropeptide Y. A novel sympathetic stress hormone and more. Ann NY Acad Sci 1995;771:219-233.
55. Giltay EJ, Hoogeveen EK, Elbers JM, et al: Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab 1998;83:550-553.
56. Ceballos G, Figueroa L, Rubio I, et al: Acute and nongenomic effects of testosterone on isolated and perfused rat heart. J Cardiovasc Pharmacol 1999;33:691-697.
57. 2 receptors in cultured rat aortic smooth muscle cells. Circ Res 1991;69:638-643.
58. 2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol 1994;267:H887-H893.
59. 2 receptors in human erythroleukemia cells. Life Sci 1996;58:683-690.
60. 2 mimetic induced coronary artery vasoconstriction in guinea pigs. Eur J Clin Invest 1994;24(suppl 1):50-52.
61. Singh H, Cheng J, Deng H, et al: Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension. Hypertension 2007;50:123-129.
62. Fujimoto R, Morimoto I, Morita E, et al: Androgen receptors, 5 alpha-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells. J Steroid Biochem Mol Biol 1994;50:169-174.
63. McCrohon JA, Jessup W, Handelsman DJ, et al: Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 1999;99:2317-2322.
64. Toda T, Toda Y, Cho BH, et al: Ultrastructural changes in the comb and aorta of chicks fed excess testosterone. Atherosclerosis 1984;51:47-57.
65. Goh HH, Loke DF, Ratnam SS: The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women. Maturitas 1995;21:65-70.
66. Adams MR, Williams JK, Kaplan JR: Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol 1995;15:562-570.
67. Alexandersen P, Haarbo J, Byrjalsen I, et al: Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 1999;84:813-819.
68. Bruck B, Brehme U, Gugel N, et al: Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1997;17:2192-2199.
69. Kolodgie FD, Jacob A, Wilson PS, et al: Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. Am J Pathol 1996;148:969-976.
70. Hayashi T, Esaki T, Muto E, et al: Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide. Arterioscler Thromb Vasc Biol 2000;20:782-792.
71. Marsh JD, Lehmann MH, Ritchie RH, et al: Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 1998;98:256-261.
72. Cabral AM, Vasquez EC, Moyses MR, et al: Sex hormone modulation of ventricular hypertrophy in sinoaortic denervated rats. Hypertension 1988;11:I93-I97.
73. Silbiger SR, Neugarten J: The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 1995;25:515-533.
74. Baylis C: Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J Clin Invest 1994;94:1823-1829.
75. Reckelhoff JF, Granger JP: Role of androgens in mediating hypertension and renal injury. Clin Exp Pharmacol Physiol 1999;26:127-131.
76. Hall JE, Mizelle HL, Hildebrandt DA, et al: Abnormal pressure natriuresis. A cause or a consequence of hypertension? Hypertension 1990;15:547-559.
77. Curtis JJ, Luke RG, Dustan HP, et al: Remission of essential hypertension after renal transplantation. N Engl J Med 1983;309:1009-1015.
78. Harrap SB, Wang BZ, MacLellan DG: Renal transplantation between male and female spontaneously hypertensive rats. Hypertension 1992;19:431-434.
79. Caplea A, Seachrist D, Dunphy G, et al: Sodium-induced rise in blood pressure is suppressed by androgen receptor blockade. Am J Physiol Heart Circ Physiol 2001;280:H1793-H1801.
80. Holla VR, Adas F, Imig JD, et al: Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc Natl Acad Sci USA 2001;98:5211-5216.
81. Guyton AC, Coleman TG, Cowley AV Jr, et al: Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972;52:584-594.
82. James GD, Sealey JE, Muller F, et al: Renin relationship to sex, race and age in a normotensive population. J Hypertens Suppl 1986;4:S387-S389.
83. Schunkert H, Danser AH, Hense HW, et al: Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997;95:39-45.
84. Chen YF, Naftilan AJ, Oparil S: Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 1992;19:456-463.
85. Ellison KE, Ingelfinger JR, Pivor M, et al: Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest 1989;83:1941-1945.
86. Morrow JD, Roberts LJ: The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997;36:1-21.
87. Miller JA, Anacta LA, Cattran DC: Impact of gender on the renal response to angiotensin II. Kidney Int 1999;55:278-285.
88. Schunkert H, Hense HW, Andus T, et al: Relation between dehydroepiandrosterone sulfate and blood pressure levels in a population-based sample. Am J Hypertens 1999;12:1140-1143.
89. Kau MM, Lo MJ, Wang SW, et al: Inhibition of aldosterone production by testosterone in male rats. Metabolism 1999;48:1108-1114.
90. Quan A, Chakravarty S, Chen JK, et al: Androgens augment proximal tubule transport. Am J Physiol Renal Physiol 2004;287:F452-F459.
91. Quinkler M, Bujalska IJ, Kaur K, et al: Androgen receptor-mediated regulation of the alpha-subunit of the epithelial sodium channel in human kidney. Hypertension 2005;46:787-798.
92. Cambotti LJ, Cole FE, Gerall AA, et al: Neonatal gonadal hormones and blood pressure in the spontaneously hypertensive rat. Am J Physiol 1984;247:E258-E264.
93. Bachmann J, Feldmer M, Ganten U, et al: Sexual dimorphism of blood pressure: possible role of the renin-angiotensin system. J Steroid Biochem Mol Biol 1991;40:511-515.
94. Skoog KM, Mangiapane ML: Area postrema and cardiovascular regulation in rats. Am J Physiol 1988;254:H963-H969.
95. 2+ mobilization. Circ Res 1997;81:885-892.
96. Chen Z, Yuhanna IS, Galcheva-Gargova Z, et al: Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999;103:401-406.
97. Dubey RK, Jackson EK: Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal Physiol 2001;280:F365-F388.
98. Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.
99. Dubey RK, Gillespie DG, Jackson EK, et al: 17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension 1998;31:522-528.
100. Mulroney SE, Woda C, Johnson M, et al: Gender differences in renal growth and function after uninephrectomy in adult rats. Kidney Int 1999;56:944-953.
101. Dubey RK, Oparil S, Imthurn B, et al: Sex hormones and hypertension. Cardiovasc Res 2002;53:688-708.
102. Sasaki T, Ohno Y, Otsuka K, et al: Oestrogen attenuates the increases in blood pressure and platelet aggregation in ovariectomized and salt-loaded Dahl salt-sensitive rats. J Hypertens 2000;18:911-917.
103. Sharkey LC, Holycross BJ, Park S, et al: Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failure-prone SHHF/Mcc-facp rats. J Mol Cell Cardiol 1999;31:1527-1537.